Epworth Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Aortic stenosis1 trial
• Heart failure1 trial
• Mantle cell lymphoma1 trial

Phase

• Phase 11 trial
• Phase 31 trial
• Phase 41 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Pfizer2 trials
• Australian and New Zealand Intensive Care Research Centre1 trial
• Hoffmann-La Roche1 trial
• The Alfred1 trial

Running trials

• Not yet recruiting

  Dilation Optimisation for Uniform Bioprosthetic Leaflet Expansion

  NCT07430267· The Alfred· Source

  Contact: Stephanie English, RN

• Active, not recruiting

  A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

  NCT06215118· Phase 1· Pfizer· Source

• Recruiting

  Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

  NCT06057402· Phase 4· Pfizer· Source

• Recruiting

  The EXCEL Registry of Patients Requiring ECMO

  NCT03793257· Australian and New Zealand Intensive Care Research Centre· Source

  Contact: Kyle Brooks, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Aortic stenosis1 recruiting
• Heart failure1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Recruiting

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  NCT06084936· Phase 3· Hoffmann-La Roche· Source